Eli Lilly, Nvidia sign five-year, up to $1B deal for AI laboratorynews2026-01-12T15:00:19+00:00January 12th, 2026|Endpoints News|
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategynews2026-01-12T12:00:35+00:00January 12th, 2026|Endpoints News|
#JPM26: Day 1 at the JP Morgan Healthcare Conferencenews2026-01-12T12:00:14+00:00January 12th, 2026|Endpoints News|
Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’snews2026-01-12T11:56:20+00:00January 12th, 2026|Endpoints News|
Roche returns to Chinese biotech MediLink for another ADC pactnews2026-01-09T13:15:44+00:00January 9th, 2026|Endpoints News|
AirNexis gets $200M to test China-derived COPD drugnews2026-01-09T13:00:40+00:00January 9th, 2026|Endpoints News|
Speculation builds about a deal for Revolution Medicinesnews2026-01-09T12:10:43+00:00January 9th, 2026|Endpoints News|
Lilly to pay $1.2B for Ventyx and its NLRP3 drugsnews2026-01-07T21:29:45+00:00January 7th, 2026|Endpoints News|
Lilly partners with protein mapping startup InduPro for up to $950Mnews2026-01-07T12:00:37+00:00January 7th, 2026|Endpoints News|
Cancer biotech Disco lines up Amgen as first pharma partnernews2026-01-07T10:00:58+00:00January 7th, 2026|Endpoints News|
